HC Sox - Annals of Internal Medicine, 2009 - Am Coll Physicians In the United States, the term off-label use means using approved drugs for clinical indications
that the US Food and Drug Administration (FDA) has not approved. Once the FDA has approved
a drug, physicians have few constraints on how they use it. In 1996 and 1997, the FDA ... Cited by 2 - Related articles - All 3 versions
EA Largent, FG Miller, SD Pearson - Archives of Internal Medicine, 2009 - Am Med Assoc Currently, there is little guidance to distinguish clearly between off-label uses that are well-supported
by evidence and those that are not. In this article, we address that gap at the level of the practicing
physician. First, we identify characteristics of off-label use that signal the need for greater ... Related articles - All 3 versions
R Dresser, J Frader - The Journal of Law, Medicine & Ethics, 2009 - interscience.wiley.com It is also possible that your web browser is not configured or not able to display style sheets.
In this case, although the visual presentation will be degraded, the site should continue to be
functional. We recommend using the latest version of Microsoft or Mozilla web browser to ... Related articles - All 5 versions
[CITATION] Going Off-label Without Venturing Off-Course
F US - Archives of Internal Medicine, 1997 - Am Med Assoc
O Delgadoa, F Puigventósa, A Clopésb - Farm Hosp, 2009 - dialnet.unirioja.es Editorial 235 El reto de disminuir los costes en el tratamiento de la anemia renal con factores
eritropoyéticos J. Hernández Jaras 237 Posicionamiento del farmacéutico de hospital ante la
utilización de medicamentos en condiciones diferentes a las autorizadas O. Delgado, F. ... Related articles - View as HTML - All 5 versions
CF ICO - iconcologia.net Page 1. PNT/Medicaments Especials/ICO Versió: Octubre 2009 PROCEDIMENT NORMALITZAT
DE TREBALL Disponibilitat de Medicaments en situacions especials al'Institut Català d'Oncologia
Comissió Farmacoterapèutica ICO President Vice-President Secretaria ... View as HTML